Clomipramine does cause weight gain, and it carries a higher risk than most other antidepressants. In controlled clinical trials for OCD, 18% of patients taking clomipramine reported weight gain, compared to just 1% on placebo. Among the tricyclic antidepressant class, clomipramine falls in the middle of the pack for weight gain potential, below amitriptyline but above imipramine.
How Much Weight Gain to Expect
A prospective study following OCD patients over 2.5 years found that the overall group gained an average of about 1.6 kg (roughly 3.5 pounds), or 2.5% of their starting body weight. But that average masks a wide range. Among patients specifically taking clomipramine, 34.8% experienced what researchers define as clinically significant weight gain: an increase of 7% or more from their baseline weight. For someone who starts at 150 pounds, that’s more than 10 pounds. By comparison, only 4.5% of patients on sertraline and 8.7% on fluoxetine hit that same threshold.
Not everyone gains weight, though. Some people notice little to no change. The research shows that weight gain on clomipramine isn’t predicted by age, sex, starting weight, or how well the medication works for the underlying condition. That makes it difficult to know in advance who will be affected most.
Why Clomipramine Promotes Weight Gain
The weight gain comes down to how the drug interacts with two receptor systems in the brain. Clomipramine blocks histamine H1 receptors and serotonin 5-HT2C receptors. Both of these normally play a role in regulating appetite and satiety. When they’re blocked, hunger signals increase and the feeling of fullness after eating is blunted. A large systematic review published in The Lancet confirmed that antidepressants with this dual receptor profile, including tricyclics like clomipramine and mirtazapine, consistently show the most weight gain.
The anticholinergic properties of clomipramine may also contribute to broader metabolic changes beyond simple appetite increases, including effects on how the body processes sugar and fat.
Effects on Blood Sugar and Metabolism
Weight gain isn’t the only metabolic concern. A retrospective analysis found that patients treated with clomipramine had nearly four times the odds of developing diabetes compared to patients not on the drug, even after accounting for age and BMI. That’s a striking association, though the researchers noted it still needs confirmation from prospective studies designed to establish cause and effect.
This means the metabolic impact of clomipramine may extend beyond the number on the scale. If you’re already at elevated risk for blood sugar problems, this is worth discussing with your prescriber, who can monitor glucose levels during treatment.
How It Compares to Other Antidepressants
Within the tricyclic class, the weight gain hierarchy is fairly well established. Amitriptyline carries the highest risk, followed by clomipramine, then imipramine. If a tricyclic is needed and weight is a primary concern, imipramine is considered the more weight-sparing option.
Among SSRIs, paroxetine stands out as the most likely to cause weight gain. Fluoxetine and sertraline sit at the opposite end, with some patients on fluoxetine actually losing weight. In the long-term OCD study, clomipramine produced significantly more weight gain than either fluoxetine or sertraline.
Outside both classes, mirtazapine is another antidepressant commonly flagged as high-risk for weight gain, sharing the same histamine-blocking mechanism. On the lower-risk end, many newer antidepressants like bupropion are considered more weight-neutral.
Managing Weight During Treatment
The most effective approach is proactive rather than reactive. Starting healthy eating habits and regular physical activity early in treatment, rather than waiting until weight has already increased, gives you the best chance of minimizing changes. This isn’t unique to clomipramine. Systematic reviews of metabolic side effects across psychiatric medications consistently point to lifestyle interventions as the primary strategy.
Tracking your weight regularly, especially in the first few months, helps you spot trends early. A gain of a few pounds in the first weeks may level off on its own, but a steady upward trajectory is worth raising with your prescriber. In some cases, switching to a medication with a lower weight gain profile may be appropriate, particularly if the metabolic effects are outweighing the therapeutic benefits. That decision depends on how well clomipramine is working for you, since it remains one of the most effective options for conditions like OCD, and the trade-off looks different for everyone.